Highlights of latest advances in antithrombotics.

2112. 13. Lassen, M. R. (2000) The EPHESUS study: comparison of the first synthetic factor Xa inhibitor with low molecular weight heparin (LMWH). The prevention of venous thromboembolism (VTE) after elective hip replacement surgery. Blood 96(11), Abstract #2109. 14. Erickson, B. (2000) The PENTHIFRA study: comparison of the first synthetic Factor Xa inhibitor with low molecular weight heparin (LMWH). The prevention of venous thromboembolism (VTE) after hip fracture surgery. Blood 96(11), Abstract #2110. 15. Bauer, K. (2000) The PENTAMAKS study: comparison of the first synthetic Factor Xa inhibitor with low molecular weight heparin. The prevention of venous thromboembolism (VTE) after elective major knee surgery. Blood 96(11), Abstract #2111. 16. Turpie, A. G. G., Gallus, A. S., and Hoek, J. A. (2001) For the pentasaccharide investigators: a synthetic pentasaccharide for the prevention of deep vein thrombosis after total hip replacement. N. Engl. J. Med. 344(9), 619–625. 18 Iqbal and Mousa CH02,9-20,12pgs 9/5/03 10:58 AM Page 182110. 15. Bauer, K. (2000) The PENTAMAKS study: comparison of the first synthetic Factor Xa inhibitor with low molecular weight heparin. The prevention of venous thromboembolism (VTE) after elective major knee surgery. Blood 96(11), Abstract #2111. 16. Turpie, A. G. G., Gallus, A. S., and Hoek, J. A. (2001) For the pentasaccharide investigators: a synthetic pentasaccharide for the prevention of deep vein thrombosis after total hip replacement. N. Engl. J. Med. 344(9), 619–625. 18 Iqbal and Mousa CH02,9-20,12pgs 9/5/03 10:58 AM Page 18